11 Jul2022

4th EULAC PerMed Summer School “Clinical Studies on PM”

Written by Mª Cristina Nieto. Posted in News

 

4th EULAC PerMed Summer School 

“Clinical studies on Personalised Medicine”

15th-16th November 2022

Wyndham All Brook Hotel in Panama City, Panama

Hybrid Platform. Due to Pandemic, it could be 100 % virtual

EULAC PerMed is a project funded by the European Commission that aims to enhance collaboration between Latin America and Caribbean countries (LAC) with Europe in the field of personalized medicine.

The Summer School (SS) has a specific focus on illustrating clinical studies’ gaps and challenges under different disease perspectives: infectious and neglected diseases, oncology diseases, cardiovascular and rare diseases. It could be a chance to create Personalised Medicine research networking between EU & LAC countries.

Organized by the Italian Ministry of Health on behalf of the EULAC PerMed consortium, and in collaboration with GORGAS Institute (Panama), the “Summer School” will take place on 15th and 16th November 2022 in Panama City, and will count on highly qualified experts in the field.

EULAC PerMed will offer a participant’s grant to 20 participants, who will be evaluated and admitted on a competitive basis.

The documents ( English) to be submitted electronically for this purpose are:
– Curriculum Vitae
– Reference letter from your institution (optional)
– Relevant publications (optional)

Application Period: 7th July – 1st September
Selection Results: 1st September- 30th September
Confirmation: First week of October, 2022

Application form: https://ec.europa.eu/eusurvey/runner/WEINbmb123

Draft Agenda

Application information 

 

Summer School Team Contacts:

The event will be “back to back” with the 3nd EULAC PerMed Technical Workshop on “Clinical trials in Personalized Medicine”. The application to both Summer School and Technical workshop can be accepted, but the evaluation for the selection will be done separately

03 May2022

1st First EU Africa PerMed Webinar: “Oncology: Personalised Medicine approach”

Written by Mª Cristina Nieto. Posted in News

Cancer is a major public health problem worldwide and is expected to surpass infectious disease as the leading cause of mortality in Africa within the next two decades.

It is a group of genomic diseases that presents with intra- and inter-population unique phenotypes. At large, the prevention and personalized treatment of cancers have been driven by the understanding of the genetic make-up of the disease of mostly non-African populations. For this, it is needed to address the knowledge gap in understanding the underlying genetic causes of, and genomic alterations associated with, cancer among black Africans.

Lastly, it is related to disparities that include socioeconomic, ethnic, racial, and cultural factors that differ between low and high-income countries.


Retinoblastoma is the most common cancer in the paediatric population and Wilms tumor (WT) is the most common renal malignancy of childhood. Both with global disparities reported indicating highest incidence and lowest survival in sub-Saharan Africa.

Recently studies are focused on identifying the constitutional mutations within the African populations.

19 Apr2022

Upcoming Events related to Personalised Medicine

Written by Mª Cristina Nieto. Posted in News

For your information, there will be several upcoming events related to personalised medicine in April and May:

Hoping that they are of your interest!

31 Jan2022

New publication of EU-STANDS4PM

Written by Mª Cristina Nieto. Posted in News

EU-STANDS4PM is a Coordinating and Support Action funded under the Horizon2020 framework programme of the European Commission. Its central goal is to develop harmonised transnational standards, recommendations and guidelines that allow a broad application of predictive in silico methodologies in personalised medicine across Europe.

A new publication of the project is recently available, focused on: Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation. 

This publication may be of interest of those research groups developing predictive computational models in the field of personalised medicine. 

25 Jan2022

ICPerMed “Best Practice in Personalised Medicine” Recognition 2021

Written by Mª Cristina Nieto. Posted in News

This is the fourth call of ICPerMed “Best Practice in Personalised Medicine” Recognition. The objective of the ICPerMed Recognition 2021 is to honour, encourage, promote and disseminate outstanding evidence-based applications in the field of personalised medicine (PM), focusing on the implementation of PM research. It is open for candidates worldwide. We encourage to present your candidatures if you are interested. 

The deadline for proposal submission is extended until 18th February 2022.

You can consult all the information related with this call here.